Liganded Pregnane X Receptor Represses the Human Sulfotransferase SULT1E1 Promoter Through Disrupting Its Chromatin Structure

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2011 Jul 19

PMID 21764778

Citations 25

Authors

Susumu Kodama

Fardin Hosseinpour

Joyce A Goldstein

Masahiko Negishi

Affiliations

Soon will be listed here.

Abstract

Pregnane X receptor (PXR), acting as a xenobiotic-activated transcription factor, regulates the hepatic metabolism of therapeutics as well as endobiotics such as steroid hormones. Given our finding that PXR activation by rifampicin (RIF) represses the estrogen sulfotransferase (SULT1E1) gene in human primary hepatocytes and hepatocellular carcinoma Huh7 cells, here we have investigated the molecular mechanism of this repression. First the PXR-responsive enhancer was delineated to a 100 bp sequence (-1000/-901), which contains three half sites that constitute the overlapping direct repeat 1 (DR1) and direct repeat 2 (DR2) motifs and two forkhead factor binding sites. siRNA knockdown, chromatin immunoprecipitation and chromatin conformation capture assays were employed to demonstrate that hepatocyte nuclear factor 4α (HNF4α) bound to the PXR-responsive enhancer, and activated the enhancer by looping its position close to the proximal promoter. Upon activation by RIF, PXR indirectly interacted with the enhancer, decreasing the interaction with HNF4α and dissolving the looped SULT1E1 promoter with deacetylation of histone 3. Removal of the DR sites from the enhancer hampers the ability of HNF4α to loop the promoter and that of PXR to repress the promoter activity. Thus, PXR represses human SULT1E1, possibly attenuating the inactivation of estrogen.

Citing Articles

Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism.

Zhao Y, Tan H, Zhang J, Zhan D, Yang B, Hong S J Nanobiotechnology. 2024; 22(1):122.

PMID: 38504208 PMC: 10953142. DOI: 10.1186/s12951-024-02356-0.

Estrogen sulfotransferase and sulfatase in steroid homeostasis, metabolic disease, and cancer.

Wang J, Feng Y, Liu B, Xie W Steroids. 2023; 201:109335.

PMID: 37951289 PMC: 10842091. DOI: 10.1016/j.steroids.2023.109335.

Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality.

Gagliardi A, Bajraktari-Sylejmani G, Barocelli E, Weiss J, Rigalli J Life (Basel). 2023; 13(8).

PMID: 37629602 PMC: 10455864. DOI: 10.3390/life13081745.

Combined Oral Contraceptives As Victims of Drug Interactions.

Li L, Yang X, Tran D, Seo S, Lu Y Drug Metab Dispos. 2023; 51(6):718-732.

PMID: 36963837 PMC: 10197201. DOI: 10.1124/dmd.122.000854.

Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway.

Zhang J, Wang N, Zheng Y, Yang B, Wang S, Wang X J Adv Res. 2022; 47:189-207.

PMID: 35718080 PMC: 10173160. DOI: 10.1016/j.jare.2022.06.006.

References

Inoue K, Negishi M . Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene. J Biol Chem. 2008; 283(16):10425-32. PMC: 2447624. DOI: 10.1074/jbc.M800729200. View

Kodama S, Koike C, Negishi M, Yamamoto Y . Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol. 2004; 24(18):7931-40. PMC: 515037. DOI: 10.1128/MCB.24.18.7931-7940.2004. View

Honkakoski P, Zelko I, Sueyoshi T, Negishi M . The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol. 1998; 18(10):5652-8. PMC: 109151. DOI: 10.1128/MCB.18.10.5652. View

Kodama S, Moore R, Yamamoto Y, Negishi M . Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem J. 2007; 407(3):373-81. PMC: 2275060. DOI: 10.1042/BJ20070481. View

Guo H, Gao C, Mi Z, Wai P, Kuo P . Phosphorylation of Ser158 regulates inflammatory redox-dependent hepatocyte nuclear factor-4alpha transcriptional activity. Biochem J. 2005; 394(Pt 2):379-87. PMC: 1482807. DOI: 10.1042/BJ20051730. View

Bhalla S, Ozalp C, Fang S, Xiang L, Kemper J . Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem. 2004; 279(43):45139-47. DOI: 10.1074/jbc.M405423200. View

Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M . A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem. 2003; 278(16):14146-52. DOI: 10.1074/jbc.M212482200. View

Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M . The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem. 1999; 274(10):6043-6. DOI: 10.1074/jbc.274.10.6043. View

Gong H, Jarzynka M, Cole T, Lee J, Wada T, Zhang B . Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res. 2008; 68(18):7386-93. PMC: 6551207. DOI: 10.1158/0008-5472.CAN-08-1545. View

10.

Song W, MOORE R, McLachlan J, Negishi M . Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant liver expression in obese and diabetogenic C57BL/KsJ-db/db mice. Endocrinology. 1995; 136(6):2477-84. DOI: 10.1210/endo.136.6.7750469. View

11.

Inoue K, Borchers C, Negishi M . Cohesin protein SMC1 represses the nuclear receptor CAR-mediated synergistic activation of a human P450 gene by xenobiotics. Biochem J. 2006; 398(1):125-33. PMC: 1525010. DOI: 10.1042/BJ20060109. View

12.

Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka M . Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol. 2007; 21(8):1781-90. DOI: 10.1210/me.2007-0187. View

13.

Hatzis P, Talianidis I . Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol Cell. 2002; 10(6):1467-77. DOI: 10.1016/s1097-2765(02)00786-4. View

14.

Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A . Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem. 2010; 285(18):13444-53. PMC: 2859504. DOI: 10.1074/jbc.M109.062430. View

15.

Yamamoto Y, Moore R, Hess H, Guo G, Gonzalez F, Korach K . Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem. 2006; 281(24):16625-31. DOI: 10.1074/jbc.M602723200. View

16.

Khor V, Dhir R, Yin X, Ahima R, Song W . Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice. Am J Physiol Endocrinol Metab. 2010; 299(4):E657-64. PMC: 2957869. DOI: 10.1152/ajpendo.00707.2009. View

17.

Lambert C, Spire C, Claude N, Guillouzo A . Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2008; 234(3):345-60. DOI: 10.1016/j.taap.2008.11.008. View

18.

Suzuki M, Ishida H, Shiotsu Y, Nakata T, Akinaga S, Takashima S . Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients. J Steroid Biochem Mol Biol. 2009; 113(3-5):195-201. DOI: 10.1016/j.jsbmb.2008.12.008. View

19.

Tolhuis B, Palstra R, Splinter E, Grosveld F, de Laat W . Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell. 2002; 10(6):1453-65. DOI: 10.1016/s1097-2765(02)00781-5. View

20.

Tong M, Jiang H, Liu P, Lawson J, Brass L, Song W . Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice. Nat Med. 2005; 11(2):153-9. DOI: 10.1038/nm1184. View